Ifosfamide-induced Fanconi syndrome with diabetes insipidus

Korean Journal of Internal Medicine

Volumn 29, Issue 2, 2014, Pages 246-249

  Leem, Ah Young ^a   Kim, Han Sang ^a   Yoo, Byung Woo ^a   Kang, Beo Deul ^a   Kim, Min Hwan ^a   Rha, Sun Young ^a   Kim, Hyo Song ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Diabetes insipidus; Fanconi syndrome; Ifosfamide

Indexed keywords

AMINO ACID; CALCIUM; CREATININE; DOXORUBICIN; GLUCOSE; IFOSFAMIDE; MESNA; NITROGEN; PHOSPHATE; POTASSIUM; SODIUM; UREA; URIC ACID; ALKYLATING AGENT;

ADULT; ARTICLE; AXILLARY MASS; CALCIUM BLOOD LEVEL; CANCER CHEMOTHERAPY; CASE REPORT; CREATININE BLOOD LEVEL; DEHYDRATION; DIABETES INSIPIDUS; ELECTROLYTE DISTURBANCE; FANCONI RENOTUBULAR SYNDROME; GLUCOSURIA; HUMAN; HYPERCALCEMIA; HYPERNATREMIA; HYPEROSMOLARITY; HYPOKALEMIA; HYPOPHOSPHATEMIA; KIDNEY TUBULE ABSORPTION; LABORATORY TEST; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; METABOLIC ACIDOSIS; MIDDLE AGED; PHOSPHATE BLOOD LEVEL; POLYDIPSIA; POLYURIA; POTASSIUM BLOOD LEVEL; PROTEINURIA; SODIUM BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; URINALYSIS; WEAKNESS; ACIDOSIS; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADVERSE EFFECTS; CHEMICALLY INDUCED; FANCONI SYNDROME; FATALITY; HISTIOCYTOMA, MALIGNANT FIBROUS; PATHOLOGY; TIME;

ACIDOSIS; ANTINEOPLASTIC AGENTS, ALKYLATING; CHEMOTHERAPY, ADJUVANT; DIABETES INSIPIDUS; FANCONI SYNDROME; FATAL OUTCOME; HISTIOCYTOMA, MALIGNANT FIBROUS; HUMANS; IFOSFAMIDE; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; TIME FACTORS;

EID: 84897837986     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2014.29.2.246     Document Type: Article

References (10)

1. Van Dyk JJ, Falkson HC, Van der Merwe AM, Falkson G. Unexpected toxicity in patients treated with iphosphamide. Cancer Res 1972;32:921-924.
2. Skinner R, Pearson AD, Price L, Coulthard MG, Craft AW. Nephrotoxicity after ifosfamide. Arch Dis Child 1990;65:732-738.
3. Rossi R, Godde A, Kleinebrand A, et al. Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity: analysis of 120 patients. J Clin Oncol 1994;12:159-165.
4. Skinner R, Pearson AD, Price L, Coulthard MG, Craft AW. The inf luence of age on nephrotoxicity following chemotherapy in children. Br J Cancer Suppl 1992;18:S30-S35.
5. Negro A, Regolisti G, Perazzoli F, Davoli S, Sani C, Rossi E. Ifosfamide-induced renal Fanconi syndrome with associated nephrogenic diabetes insipidus in an adult patient. Nephrol Dial Transplant 1998;13:1547-1549.
6. Ingemi AI, Bota VM, Peguero A, Charpentier M. Fanconi's syndrome and nephrogenic diabetes insipidus in an adult treated with ifosfamide. Pharmacotherapy 2012;32:e12-e16.
7. Zamlauski-Tucker MJ, Morris ME, Springate JE. Ifosfamide metabolite chloroacetaldehyde causes Fanconi syndrome in the perfused rat kidney. Toxicol Appl Pharmacol 1994;129:170-175.
8. Yaseen Z, Michoudet C, Baverel G, Dubourg L. Mechanisms of the ifosfamide-induced inhibition of endocytosis in the rat proximal kidney tubule. Arch Toxicol 2008;82:607-614.
9. Chen N, Aleksa K, Woodland C, Rieder M, Koren G. N-Acetylcysteine prevents ifosfamide-induced nephrotoxicity in rats. Br J Pharmacol 2008;153:1364-1372.
10. Hanly L, Chen N, Rieder M, Koren G. Ifosfamide nephrotoxicity in children: a mechanistic base for pharmacological prevention. Expert Opin Drug Saf 2009;8:155-168.